Sumitovant Biopharma Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 206,500 shares at $13.08 ($2.7M) on 2020-02-19, disclosed to the SEC on 2020-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.08 | 12,873 | $168K | 6.2% |
| 2 | $13.08 | 12,873 | $168K | 6.2% |
| 3 | $13.08 | 15,165 | $198K | 7.3% |
| 4 | $13.08 | 15,165 | $198K | 7.3% |
| 5 | $13.08 | 75,212 | $984K | 36.4% |
| 6 | $13.08 | 75,212 |
| $984K |
| 36.4% |
| Total | $13.08 avg | 206,500 | $2.7M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |